Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.remediumlifecare.com | |
Market Cap | 89.64 Cr. | |
Enterprise Value(EV) | 89.09 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 22.79 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 10.92 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 64.78 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 37.84 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 6.58 | Calculated using Price: 249.00 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.36 Cr. | 3,600,000 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets. |
1 Day |
|
-4.21% |
1 Week |
|
+22.87% |
1 Month |
|
+80.76% |
3 Month |
|
+78.49% |
6 Month |
|
+81.09% |
1 Year |
|
+79.14% |
2 Year |
|
+340.71% |
5 Year |
|
|
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 1.06 | 21.40 | 0.36 | 0.11 | 0.45 | 0.26 | 8.62 | 13.33 | 24.51 | |
Return on Capital Employed (%) | 1.50 | 24.60 | 0.66 | 0.14 | 0.55 | 0.62 | 11.16 | 7.39 | 18.16 | |
Return on Assets (%) | 0.38 | 8.92 | 0.21 | 0.09 | 0.42 | 0.24 | 7.11 | 2.25 | 0.82 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 14 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 11 | |||||
Curr. Liab. | 5 | 3 | 2 | 0 | 0 | 0 | 1 | 24 | 219 | 276 | |
Minority Int. | |||||||||||
Equity & Liab. | 7 | 6 | 5 | 3 | 3 | 4 | 4 | 39 | 224 | 290 | |
Non Curr. Assets | 3 | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||
Curr. Assets | 5 | 3 | 4 | 2 | 2 | 4 | 4 | 38 | 224 | 290 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 7 | 6 | 5 | 3 | 3 | 4 | 4 | 39 | 224 | 290 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 3 | 2 | 4 | 1 | 0 | 0 | 3 | 90 | 505 | 504 | |
Other Income | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | |
Total Income | 3 | 3 | 4 | 1 | 0 | 0 | 3 | 90 | 505 | 506 | |
Total Expenditure | -3 | -2 | -4 | -1 | 0 | 0 | -3 | -89 | -503 | -495 | |
PBIDT | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 10 | |
Interest | 0 | 0 | 0 | 0 | 0 | ||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Exceptional Items | -2 | ||||||||||
PAT | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 8 | ||
Adjusted EPS | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 23 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -1 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -10 | 11 | |
Cash Fr. Inv. | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | 10 | -11 | |||
Net Change | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Tue, 24 Jan 2023
Clarification sought from Remedium Lifecare Ltd The Exchange has sought clarification from Remedium Lifecare Ltd on January 23 2023 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited. |
Tue, 24 Jan 2023
Clarification On Price Movement Clarification on Price Movement |
Sat, 14 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2022. |
Fri, 27 Jan 2023 |
|
|
|
|
|